Sana Biotechnology Inc reports results for the quarter ended in June - Earnings Summary

Sana Biotechnology

04/08/2023 04:15

* Sana Biotechnology Inc  SANA.OQ  reported a quarterly
adjusted
loss of 45 cents​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of 43 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Sana Biotechnology Inc's reported EPS for the quarter was
a loss
of 59 cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Sana Biotechnology Inc shares had fallen by 6.2% this
quarter and gained 41.5% so far this year.
    * The company reported a quarterly loss of $114 million.
    * Wall Street's median 12-month price target for Sana
Biotechnology Inc is $11.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 4 at 03:15 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.43          -0.45          Missed
 Mar. 31 2023      -0.45          -0.43          Beat
 Dec. 31 2022      -0.51          -0.38          Beat
 Sep. 30 2022      -0.53          -0.45          Beat